Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CS12192 effectively treats alopecia areata with better safety than current options.

The tool iCOUNT helps understand how stem cells divide and affect tissue development and repair.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

ABCG2 protein marks stem-like skin cells in human epidermis.

PTCH gene mutations contribute to basal cell carcinoma development.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

ILC1-like cells can cause alopecia areata by themselves.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

AgK114 protein helps in hamster skin injury recovery.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

CD133+ cells are crucial for hair growth.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

CD2 might be a new treatment target for patchy alopecia areata.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Somatic BHD mutations are rare in Japanese renal tumors.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.